PR Newswire

TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and ...

Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data Collaboration will expand ...
Vietnam Investment Review on MSN

TriNetX and Regeneron partner on 300 million patient health records

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 3, 2026 /PRNewswire/ -- TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...
ascopubs.org

Prognostic impact and racial disparities of chromosome 8q gains in prostate cancer: Insights from integrated molecular profiling.

Comparative outcomes of abiraterone and androgen receptor inhibitors (ARPIs) in metastatic castration-sensitive prostate cancer (mCSPC): A real-world analysis from the TriNetX database. This is an ...
ascopubs.org

Outcomes in liver transplant recipients with and without obesity: A propensity-matched analysis using the TriNetX database.

Racial disparities in major adverse cardiovascular and cerebrovascular events outcomes among hospitalized cholangiocarcinoma patients.